Market outlook of the vitamin D testing market in the US
Technavio market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.
The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.
Application-based segmentation and analysis of - 25-Hydroxy vitamin D tests & 1,25-Dihydroxy vitamin D test
In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
25-Hydroxy vitamin D tests
1,25-Dihydroxy vitamin D test
Competitive landscape and key vendors - Roche Diagnostics, Abbott Diagnostics
This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.
Key vendors in this market are -
Siemens Healthcare Diagnostics
Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Growth drivers, challenges, and upcoming drivers - Vitamin D
Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Key questions answered in the report include
What will the market size and the growth rate be in 2019?
What are the key factors driving the vitamin D testing market in the US?
What are the key market trends impacting the growth of the vitamin D testing market in the US?
What are the challenges to market growth?
Who are the key vendors in the vitamin D testing market in the US?
What are the market opportunities and threats faced by the vendors in the vitamin D testing market in the US?
Trending factors influencing the market shares of the US?
What are the key outcomes of the five forces analysis of the vitamin D testing market in the US?
Technavio also offers customization on reports based on specific client requirement.
Global Vitamin B-complex Ingredients Market 2015-2019
Global Vitamin D Testing Market 2015-2019
Global Vitamin Ingredients Market 2015-2019
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
Key market highlights
PART 05: Vitamin D status in US
Methods for vitamin D testing
Standardization program for vitamin D test in US
PART 06: Vitamin D testing market by volume in US 2015-2019
Market size and forecast
PART 07: Market landscape
Market size and forecast
Five forces analysis
PART 08: Market segmentation by application
25-hydroxy vitamin D test
1, 25-dihydroxy vitamin D test
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
Key prominent vendors
Other prominent vendors
PART 15: Key vendor analysis
Siemens Healthcare Diagnostics
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Vitamin D sources
Exhibit 03: FDA approved products for vitamin D testing in US
Exhibit 04: Market opportunity for vitamin D testing in chronic kidney diseases
Exhibit 05: Phases of standardization program
Exhibit 06: Total volume of vitamin D tests performed in US 2015-2019 (millions)
Exhibit 07: Segmentation of vitamin D testing market in US
Exhibit 08: Vitamin D testing market in US 2015-2019 by sales revenue ($ millions)
Exhibit 09: Five forces analysis
Exhibit 10: Vitamin D testing market in US based on application
Exhibit 11: Vitamin D testing market by application in 2014
Exhibit 12: Impact of drivers
Exhibit 13: Impact of drivers and challenges
Exhibit 14: Abbott Diagnostics: Key takeaways
Exhibit 15: bioMérieux: Key takeaways
Exhibit 16: DiaSorin: Key takeaways
Exhibit 17: Quest Diagnostics: Key takeaways
Exhibit 18: Roche Diagnostics: Key takeaways
Exhibit 19: Siemens Healthcare Diagnostics: Key takeaways
Exhibit 20: Abbott Diagnostics: Key business offerings
Exhibit 21: bioMérieux: Applications by technology
Exhibit 22: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 23: DiaSorin: Geographical segmentation by revenue 2014
Exhibit 24: Quest Diagnostics: Business segmentation
Exhibit 25: Quest Diagnostics: Business segmentation by revenue 2014
Exhibit 26: Quest Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
Exhibit 30: Siemens Healthcare Diagnostics: Business segmentation
Exhibit 31: Siemens Healthcare Diagnostics: Geographical segmentation by revenue 2014